Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a104
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin85
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future72
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review65
Challenges in preserving antibiotic effectiveness: time for a novel approach63
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis51
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies47
Neonatal ocular prophylaxis in the United States: is it still necessary?40
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex40
Visceral leishmaniasis elimination in India: progress and the road ahead39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia39
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72035
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies35
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?29
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis28
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China27
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections25
Treatment of vaginitis caused by non-albicans Candida species25
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis24
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges23
Identifying predictors of treatment failure with community-acquired pneumonia: an update23
Reemergence of monkeypox: prevention and management23
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?22
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies22
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin22
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective22
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections21
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline21
Diagnostic and clinical management of Candida auris infections in immunocompromised patients20
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review19
Infliximab as a potential treatment for COVID-1918
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges18
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures17
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-1917
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases17
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta17
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies17
Diagnostic and management strategies for chronic hepatitis E infection16
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development16
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases16
Statement of Retraction15
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury15
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections15
Correction15
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review14
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)14
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae14
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India14
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?14
The serological dilemma: rethinking syphilis treatment evaluation14
The evolving debate around screening for Chlamydia trachomatis13
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches13
Diagnosing fungal infections in clinical practice: a narrative review13
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana13
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae13
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat13
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea12
How can we tackle the overuse of antibiotics in low- and middle-income countries?12
Monoclonal antibodies for the treatment of COVID-19 infection in children12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas12
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae12
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection11
Gram-positive infections in special populations. Expert view on the role of dalbavancin11
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study11
Challenges associated with pertussis detection, monitoring, and vaccination in adults11
Now that griseofulvin is not available, what to do with tinea capitis treatments?11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision11
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials10
Tocilizumab for the treatment of COVID-1910
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents10
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study10
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers10
New insights into the treatment of acute otitis media10
How do we best manage Clostridioides difficle infections in the elderly?10
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals10
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis10
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials9
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options9
Ivermectin: a pathway out of the pandemic or another dead end?9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-199
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients9
Artificial intelligence and prescription of antibiotic therapy: present and future9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients9
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies9
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo9
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial8
An update on newer antifungals8
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak8
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV8
Global importance of new treatment strategies to efforts to control hepatitis B virus8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan8
Past, present, and future perspectives on aztreonam and avibactam8
A systems thinking approach for antimicrobial stewardship in primary care8
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis8
Strengths and caveats of identifying resistance genes from whole genome sequencing data8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects8
Containment strategies for COVID-19 in India: lessons from the second wave8
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis8
0.04436993598938